Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Italian Stock Exchange  >  DiaSorin SpA    DIA   IT0003492391

DIASORIN SPA (DIA)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Italian Stock Exchange
02/13/2018 02/14/2018 02/15/2018 02/16/2018 02/19/2018 Date
71(c) 70(c) 70.4(c) 71.3(c) 69.9 Last
60 963 98 122 92 225 104 101 97 296 Volume
-0.28% -1.41% +0.57% +1.28% -1.96% Change
More quotes
Financials (€)
Sales 2017 638 M
EBIT 2017 193 M
Net income 2017 131 M
Finance 2017 118 M
Yield 2017 1,26%
Sales 2018 709 M
EBIT 2018 217 M
Net income 2018 154 M
Finance 2018 219 M
Yield 2018 1,43%
P/E ratio 2017 29,12
P/E ratio 2018 25,59
EV / Sales2017 6,06x
EV / Sales2018 5,32x
Capitalization 3 989 M
More Financials
Company
DiaSorin SpA engages in the development, production, and marketing of reagent kits for in vitro diagnostics.It specializes in the provision of immunodiagnostics and molecular diagnostics solutions which meet the needs of the following clinical areas: infectious diseases, cardiac markers, bone... 
More about the company
Surperformance© ratings of DiaSorin SpA
Trading Rating : Investor Rating :
More Ratings
Latest news on DIASORIN SPA
01/30DIASORIN : Signs an agreement with the italian tax authority granting tax relief..
PU
2017DIASORIN : Federal Contracts Awarded by Federal Agencies in Texas (Dec. 22)
AQ
2017DIASORIN : MILITARY $92,935 Federal Contract Awarded to DiaSorin Molecular
AQ
2017DIASORIN : Launches a new simplexa bordetella direct molecular test
PU
2017DIASORIN : Resignation of a Strategic Executive of the Company
PU
2017DIASORIN : Reagent Kits
AQ
2017DIASORIN : Molecular Receives FDA Clearance for C. difficile Assay
AQ
2017DIASORIN : Growth in revenues and net profit in q3 2017. strong free cash flow g..
PU
2017DIASORIN : Molecular Introduces Analyte-Specific Reagents for Streptococcus
AQ
2017DIASORIN SPA : quaterly earnings release
More news
Sector news : Diagnostic & Testing Substances
02/15STRYKER : U.S. Regulators Extend Window for Critical Stroke Treatment
DJ
02/15STRAUMANN : margin outlook takes shine off revenue surge
RE
02/15COLOPLAST A/S : ConvaTec beats low full-year expectations, shares rise
RE
02/07ESSILOR INTERNATIONAL : Makes Changes to Board of Directors
DJ
02/06BECTON DICKINSON AND : Revenue Helped by Life-Sciences -- Earnings Review
DJ
More sector news : Diagnostic & Testing Substances
Latest Tweets
02/15Jefferies Group Sets Diasorin FY2017 Earnings Estimates at $3.53 EPS.  
01/08BRIEF-Qiagen, DiaSorin partner in automated tuberculosis detection  
01/08BRIEF-Diasorin And Qiagen Partner To Offer Fully Automated Solution For Diagn.. 
01/08QIAGEN and DiaSorin Partner to Offer Fully Automated Tuberculosis Detection W.. 
01/08Partnership tra DiaSorin e Qiagen  
More tweets
Qtime:68
News from SeekingAlpha
2017Diasorin SPA ADR 2017 Q3 - Results - Earnings Call Slides 
2017DiaSorin (DSRLF) Investor Presentation - Slideshow 
2016Winner And Losers Among Italian Companies 
2016Diasorin SPA ADR 2016 Q3 - Results - Earnings Call Slides 
2016DiaSorin buys Quest's diagnostic products business for $300M 
Chart DIASORIN SPA
Duration : Period :
DiaSorin SpA Technical Analysis Chart | DIA | IT0003492391 | 4-Traders
Technical analysis trends DIASORIN SPA
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 10
Average target price 78,8 €
Spread / Average Target 10%
EPS Revisions
Managers
NameTitle
Carlo Rosa Chief Executive Officer, Executive Director & GM
Gustavo Denegri Chairman
Piergiorgio Pedron Chief Financial Officer & Senior Corporate VP
Chen Menachem Even Executive Director & SVP-Commercial Operations
Franco Moscetti Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
DIASORIN SPA-4.86%4 939
BIOMERIEUX-4.67%10 568
AUTOBIO DIAGNOSTICS CO LTD-11.42%3 121
MACCURA BIOTECHNOLOGY CO LTD--.--%1 903
SIEGFRIED HOLDING AG-1.39%1 463
SHANGHAI KEHUA BIO-ENGINEERING CO LTD--.--%964